Exemplis Discimus 2005, 149(2):339-343

Morbi quis lectus at dolor dignissim consectetuer.

Jethro Crackena, Peggy Dalledosa, Antaki Drayvena, Banbl Akuraa, Acacia Chrob, Canna Wystalinc, Quin Marogonc, Zylas Laatla, Wan Flotoa
a Department of Obstetrics and Gynecology, Senex Faculty Hospital, Mygeeto Republic
b Centre of Operation Room Technology, University of Cadavine, Republic of Iego
c Centre of Pediatric Dentistry, Faculty Hospital of Duro, Republic of Subterrel

Cras est nibh, molestie eget, malesuada in, vulputate vel, leo. Maecenas elit elit, condimentum in, vehicula quis, eleifend et, purus. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Vivamus placerat elit ac sem facilisis lobortis. Aenean tortor dui, rhoncus id, laoreet ac, euismod in, diam. Nullam eget justo in quam condimentum feugiat. Maecenas quis odio quis purus dapibus suscipit. Phasellus ligula dolor, consectetuer viverra, accumsan vel, posuere et, lectus.

Keywords: Morbi in magna, Morbi ac felis, Fusce ac diam, Vivamus felis, Pellentesque sem

Received: June 10, 2005; Accepted: September 25, 2005; Published: December 1, 2005 


References

  1. Reilly CS, Wood M, Koshakji RP, Wood AJ. (1985) Ultra-short acting beta-blockade: a comparison with conventional beta-blockade. Clin Pharmacol Ther 38, 579-85 Go to original source... Go to PubMed...
  2. Murthy VS, Frishman WH. (1988) Controlled beta-receptor blockade with esmolol and flestolol. Pharmacotherapy 8,168-82. Go to PubMed...
  3. Grohs JG, Fischer G, Raberger G. (1990) Effects of flestolol, an ultra-short acting beta-adrenoceptor antagonist, on hemodynamic changes produced by treadmill exercise or isoprenaline stimulation in conscious dogs. J Cardiovasc Pharmacol 15,175-81. Go to original source... Go to PubMed...
  4. Felix SB, Stangl V, Kieback A, Doerffel W, Staudt A, Wernecke KD, Baumann G, Stangl K.(2001) Acute hemodynamics effects of beta blockers in patiens with severe congestive heart failure: comparison of celiprolol and esmolol. J Cardiovasc Pharmacol 38, 666-71. Go to original source... Go to PubMed...
  5. Bebarova M, Matejovic P, Pasek M, Simurdova M, Simurda J. (2005) Effect of ajmaline on transient outward current in rat ventricular myocytes. Gen Physiol Biophys - in print.
  6. Bartosova L, Frydrych M, Hulakova G, Berankova M, Strnadova V, Mokry P, Brunclik V, Kolevska J, Bebarova M. (2004) Efficacy of Newly Synthesized, 44Bu Ultrashort-Acting, Beta-Adrenergic Antagonist to Isoprenaline-Induced Tachycardia - Comparison With Esmolol. Acta Vet Brno 73, 171-9. Go to original source...
  7. Catterall WA. (1980) Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Annu Rev Pharmacol Toxicol 20, 15-43. Go to original source... Go to PubMed...
  8. Muroi M, Kimura I, Kimura M. (1990) Blocking effects of hypoaconite and aconitine on nerve action potentials in phrenic nervediaphragm muscles of mice. Neuropharmacology 29, 567-72. Go to original source... Go to PubMed...
  9. Friese J, Gleitz J, Gutser UT, Heubach JF, Matthiesen T, Wilffert B, Selve N. (1997) Aconitum sp. Alkaloids: the modulation of voltagedependent Na+ channels, toxicity and antinociceptive properties. Eur J Pharmacol 337, 165-74. Go to original source... Go to PubMed...
  10. Catterall WA, Trajner V, Baden DG. (1992) Molecular properties of the sodium channel: A receptor for multiple neurotoxins. Bul Soc Pathol Exot 85, 481-5.
  11. Ameri A. (1998) The effects of Aconitum alkaloids on the central nervous system. Progress in Neurobiology 56, 211-35. Go to original source... Go to PubMed...
  12. Sterling NW. (2001) Irreversible block of human heart (hH1) sodium channels by plant alkaloid lappaconitine Mol Pharmacology 59, 183-92.
  13. Hille B. Modifiers of gating. Ionic channels of excitable membranes. Sunderland, MA: Sinauer, 1992. p. 445-71.
  14. Catteral WA. (1987) Common modes of drug action on Na+ channels: local anaesthetics, antiarrhythmics and anticonvulsants. Trends Pharmac Sci 8, 57-65. Go to original source...
  15. Wang SY, Wang GK. (1999) Batrachotoxin-resistant Na+ channels derived from point mutations in transmembrane segment D4-S6. Biophys J 76, 3141-9. Go to original source... Go to PubMed...